Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer
Michael C. Quinn(New South Wales Department of Health), Melissa Moffitt(Oregon Health & Science University), Allan Jensen(Danish Cancer Society), Yi Lu(Karolinska Institutet), Jonathan P. Tyrer(University of Cambridge), Dylan M. Glubb(QIMR Berghofer Medical Research Institute), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Bryan M. McCauley(University of Minnesota), Peter A. Fasching(Universitätsklinikum Erlangen), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Claus Høgdall(Copenhagen University Hospital), Line Bjørge(Haukeland University Hospital), Michael Friedländer(Prince of Wales Hospital), Thilo Dörk(Hannover Re (Germany)), Marjorie J. Riggan(Duke Medical Center), Estrid Høgdall(University of Copenhagen), Ann‐Marie Patch(QIMR Berghofer Medical Research Institute), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Jacobus Pfisterer(Gynecologic Oncology Group), Andrew Berchuck(General Marble (Greece)), Matthias W. Beckmann(Universitätsklinikum Erlangen), Digna R. Velez Edwards(Vanderbilt University Medical Center), Andreas du Bois(Kliniken Essen-Mitte), Karen McCue(Guy's Hospital), Kathryn L. Terry(Brigham and Women's Hospital), Javier Benı́tez(Spanish National Cancer Research Centre), Kirsten B. Moysich(American Cancer Society), Ignace Vergote(KU Leuven), Daniel W. Cramer(Brigham and Women's Hospital), Joellen M. Schildkraut(Duke University Hospital), Jue‐Sheng Ong(QIMR Berghofer Medical Research Institute), Wei Shi(Affiliated Hospital of Shandong University of Traditional Chinese Medicine), Tanja Pejović(Oregon Health & Science University), Bo Gao(Sun Yat-sen University), Sebastian M. Armasu(Mayo Clinic in Florida), Tracy A. O’Mara(QIMR Berghofer Medical Research Institute), Francesmary Modugno(University of Pittsburgh), Klaus Bauman(Philipps University of Marburg), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Matthias Dürst(Jena University Hospital), Beth Y. Karlan(University of California, Los Angeles), Jenny Lester, María J. García(Spanish National Cancer Research Centre), Andrew Civitarese(QIMR Berghofer Medical Research Institute), Melissa C. Larson(Mayo Clinic), Alicia Beeghly‐Fadiel(University of Helsinki), Julie M. Cunningham(Cancer Research UK), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Puya Gharahkhani(Queensland University of Technology)
Cited by 13
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k